Ehrlichia chaffeensis infections among HIV-infected patients in a human monocytic ehrlichiosis-endemic area

Emerging Infectious Diseases

Volumn 9, Issue 9, 2003, Pages 1123-1127

  Talbot, Thomas R ^a,c   Comer, James A ^b   Bloch, Karen C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; ENDEMIC DISEASE; EPIDEMIOLOGY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; INCIDENCE; INFESTATION; MAJOR CLINICAL STUDY; MALE; MONOCYTIC EHRLICHIOSIS; SEASONAL VARIATION; SERODIAGNOSIS; SEROEPIDEMIOLOGY; SEROPREVALENCE; TICK; TICK BORNE DISEASE;

EID: 0042817976     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0909.020560     Document Type: Article

References (16)

1. Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987;316:853-6.
2. Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin North Am 1998;12:123-36.
3. Yevich SJ, Sanchez JL, DeFraites RF, Rives CC, Dawson JE, Uhaa IJ, et al. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 1995;171:1266-73.
4. Safdar N, Love RB, Maki DG. Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis 2002;8:320-3.
5. Paddock CD, Folk SM, Shore GM, Machado LJ, Huycke MM, Slater LN, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with HIV. Clin Infect Dis 2001;33:1586-94.
6. Sadikot R, Shaver MJ, Reeves WB. Ehrlichia chaffeensis in a renal transplant recipient. Am J Nephrol 1999;19:674-6.
7. Paddock CD, Suchard DP, Grumbach KL, Hadley WK, Kerschmann RL, Abbey NW, et al. Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med 1993;329:1164-7.
8. Martin GS, Christman BW, Standaert SM. Rapidly fatal infection with Ehrlichia chaffeensis. N Engl J Med 1999;341:763-4.
9. Shore GM. Rapidly fatal seronegative ehrlichiosis as the first opportunistic infection in an immunodeficient man [abstract C115]. Abstracts of the General Meeting of the America Society for Microbiology, May 4-8,1997; 1997. Washington, DC: American Society for Microbiology; 1997. p. 140.
10. Carpenter CF, Gandhi TK, Kong LK, Corey GR, Chen SM, Walker DH, et al. The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. J Infect Dis 1999;180:900-3.
11. Fritz CL, Kjemtrup AM, Conrad PA, Flores GR, Campbell GL, Schriefer ME, et al. Seroepidemiology of emerging tickborne infectious diseases in a northern California community. J Infect Dis 1997;175:1432-9.
12. Standaert SM, Dawson JE, Schaffner W, Childs JE, Biggie KL, Singleton J Jr, et al. Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 1995;333:420-5.
13. Comer JA, Nicholson WL, Olson JG, Childs JE. Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol 1999;37:558-64.
14. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep Recommend Rep 1997;46(RR-10):1-55.
15. Marshall GS, Jacobs RF, Schutze GE, Paxton H, Buckingham SC, DeVincenzo JP, et al. Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med 2002;156:166-70.
16. Opravil M, Fierz W, Matter L, Blaser J, Luthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991;84:185-9.